コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 poptosis and p21 repression may also have an anticancer effect.
2 minimal toxicity, and 11a gave a significant anticancer effect.
3 te mechanism by which ibuprofen may exert an anticancer effect.
4 to new clinical strategies to strengthen its anticancer effect.
5 inhibitor with gemcitabine has a synergetic anticancer effect.
6 tion of BRD9 is hypothesized to result in an anticancer effect.
7 e's glutaminase activity enables its maximal anticancer effect.
8 gold complex that targets HMOX2 to elicit an anticancer effect.
9 with stage IV NSCLC, suggesting a potential anticancer effect.
10 vity is not always required for the enzyme's anticancer effect.
11 ng antibodies (nAbs) that can diminish their anticancer effect.
12 amycin (mTOR) inhibitors like sirolimus have anticancer effects.
13 of drug cocktails while boosting synergistic anticancer effects.
14 own to bind G-quadruplex structures, showing anticancer effects.
15 bilize the G-quadruplexes were shown to have anticancer effects.
16 f the benefits of lifelong CR, including its anticancer effects.
17 ce and telomere-based crisis, exert powerful anticancer effects.
18 ith cerebroprotective, cardioprotective, and anticancer effects.
19 poptosis even in the absence of demonstrable anticancer effects.
20 their immunosuppressive and/or antiviral and anticancer effects.
21 oformulations that boost immunity and strong anticancer effects.
22 -induced lipotoxicity to further enhance its anticancer effects.
23 targeting compounds endowed with synergistic anticancer effects.
24 bitors Physcion and its derivative S3, shows anticancer effects.
25 n the methanol extract, correlating with its anticancer effects.
26 r drug discovery, exhibiting antioxidant and anticancer effects.
27 cing oxidative stress, hence enhancing their anticancer effects.
28 e questions about the true mechanisms of its anticancer effects.
29 ssessing antioxidant, anti-inflammatory, and anticancer effects.
30 acts and constituents were studied for their anticancer effects.
31 primary mechanisms by which MNs exert their anticancer effects.
32 instant antibacterial effects and sustained anticancer effects.
33 mittent calorie restriction (ICR) have shown anticancer effects.
34 antiviral, antimalarial, antimetabolic, and anticancer effects.
35 stituent (6a and 6b) exhibited the strongest anticancer effects.
36 r more than 50 years, has been shown to have anticancer effects.
37 ortant roles in metformin's antidiabetic and anticancer effects.
38 n of phenothiazines as a class of drugs with anticancer effects.
39 ol), involve pro-apoptotic ceramide in their anticancer effects.
40 ly bioactive product that exhibits potential anticancer effects.
41 ulatory effects that may contribute to their anticancer effects.
42 e nanoparticle intratumoral distribution and anticancer effects.
43 ulation of regulatory T cells, and preserved anticancer effects.
44 an be targeted by small molecules to achieve anticancer effects.
45 molecular mechanisms by which it exerts its anticancer effects.
46 ng antibodies (nAbs) that can diminish their anticancer effects.
47 suggesting a possible association with their anticancer effect; (2) multiple HMG boxes contributed ad
49 ss the avenues investigated to harness their anticancer effects against primary and metastatic CNS tu
50 administered in animal models to achieve an anticancer effect and by the even higher doses required
51 e functionalization with peptides for better anticancer effect and current challenges in peptide-func
52 ates a new mechanism for the emodin-mediated anticancer effect and justifies further investigation of
54 ndrial dysregulation to improve the in vitro anticancer effect and suppression of cancer cell metasta
55 iofrequency (RF) ablation has shown superior anticancer effects and greater survival benefit with res
57 produce stable nanocombinations with potent anticancer effects and improved immunological functions.
59 ynchronized delivery system elicits enhanced anticancer effects and merits further development in the
61 treatment outcomes by producing synergistic anticancer effects and slowing the development of drug-r
63 substances have been shown to have numerous anticancer effects, and indeed the inhibition of FAAH ha
64 tea, has been shown, for example, to possess anticancer effects, anti-HIV effects, neuroprotective ef
70 serine in malignant cells mediates superior anticancer effects as compared with limiting either sour
71 likely to be an important mechanism for its anticancer effects because it protects cutaneous APC fro
73 cing DNA hypomethylation may have short-term anticancer effects, but might also help speed tumor prog
74 binding pocket of the N-terminal domain have anticancer effects, but most bind with similar affinity
76 eukin-7 (IL-7) and IL-12 achieves remarkable anticancer effects by activating complementary pathways
77 tat, a histone deacetylase inhibitor, exerts anticancer effects by both histone and nonhistone-mediat
79 ed nanostructures here demonstrated improved anticancer effects by enhancing tumor targeting, deliver
80 ctor 1 levels, whereas a KD exerts potential anticancer effects by increasing beta hydroxybutyrate le
81 drugs (NSAIDs) are believed to mediate their anticancer effects by inducing apoptosis but the molecul
82 involving mice, wf-UMP demonstrated notable anticancer effects by inducing tumor cell apoptosis, amp
83 potent extract (HEM UD) was studied for its anticancer effects by MTT assay against the MCF-7 and He
84 = 0.495 muMm HCT-116 cells) shows promising anticancer effects by reducing colony formation and indu
86 illustrate how Hsp70 inhibitors mediate the anticancer effects by targeting both tumor cells and tum
89 of HDACI and the ganciclovir (GCV)-mediated anticancer effect contributed by HDACI-induced and p21-d
90 6) has been targeted in clinical studies for anticancer effects due to its role in oncogenic transfor
92 nese herbal medicine, is reported to exhibit anticancer effects; however, its mechanism of action is
93 n of cyclooxygenase (COX) with NSAIDs has an anticancer effect in animal models of colon, urinary bla
95 g Hu5F9-G4 with trastuzumab would produce an anticancer effect in antibody-dependent cellular cytotox
96 Cytotoxicity assays revealed ZnO's potent anticancer effect in Caco-2 cells with an IC50 of 219 ug
97 the first dual binder 3 possessing a higher anticancer effect in GBM cells than the standards PK1119
98 he evidence suggests that ICR exerts greater anticancer effect in genetically engineered mouse models
99 emonstrate that RARbeta may exert its potent anticancer effect in part through its unique anti-AP-1 a
100 taxel or vinorelbine exhibited a synergistic anticancer effect in these human breast cancer cells in
101 potent SIRT2-specific inhibitor with a broad anticancer effect in various human cancer cells and mous
103 l machinery can lead to potent and selective anticancer effects in cancers dependent on high and cons
104 SYK and EGFR coinhibition exerts synergistic anticancer effects in chemoresistant ovarian cancer, pro
105 etic properties and a notable enhancement of anticancer effects in combination with an mAb immune che
109 How DNA methylation inhibitors exert their anticancer effects in patients is not well understood.
110 ase, and zoledronic acid has shown potential anticancer effects in preclinical and clinical studies.
111 targeting of interleukin 2 shows synergistic anticancer effects in the treatment of FAP-positive tumo
112 RM1i and PI3K inhibitor elicited synergistic anticancer effects in TNBC cell lines, organoids, and pa
113 that the compound 5c significantly produced anticancer effects in vitro and in vivo by reducing the
114 e micellar nanocomplexes, which have greater anticancer effects in vitro and in vivo than the free pr
115 nger protein PARP-1 indicate that they exert anticancer effects in vitro based on different mechanism
118 RNAi targeting FAS gene demonstrate systemic anticancer effects in vivo, our results render FAS as a
120 roposed mechanism by which PS-341 exerts its anticancer effect is inactivation of nuclear factor-kapp
126 s, besides their well-investigated cytotoxic anticancer effects, massively interact with the cancer-i
127 oral administration, we propose that maximum anticancer effect may be achieved by nanoemulsion mediat
129 inhibition of cyclooxygenase-1, whereas its anticancer effects may be due to inhibition of cyclooxyg
133 ibitor, suggesting a promising combinatorial anticancer effect of AhR and EGFR pathway inhibition.
136 We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permea
139 em that has the potential for evaluating the anticancer effect of HDACIs on cancer cells by multiple
143 d with NDI, thus further indicating that the anticancer effect of NDI/2DG combination was indeed due
152 d and translate our observations on in vitro anticancer effect of silibinin/silymarin to an in vivo p
154 ue of the JCI, Li et al. explored the potent anticancer effect of the combination of a glutaminase in
155 to investigate the chemical composition and anticancer effect of the leaf essential oil of Xylopia f
159 nce to trametinib as well as the synergistic anticancer effect of trametinib combined with immunother
164 we report the synthesis and investigation of anticancer effects of a series of water-soluble fulleren
166 e used as a novel strategy to potentiate the anticancer effects of adoptively infused NK cells in pat
171 is, combined with the recent findings of the anticancer effects of bisphosphonates, cyclooxygenase-2
174 indings provide mechanistic insight into the anticancer effects of ceramide and preclinical evidence
179 ochemical studies indicating that the potent anticancer effects of CR and disrupted insulin/IGFI rece
181 ternative strategies are required to improve anticancer effects of current chemotherapeutics while li
184 This novel effect may contribute to the anticancer effects of DIM because IFNgamma plays an impo
185 t may provide important clues to explain the anticancer effects of DIM because it is well known that
186 lates gene transcription and reveal that the anticancer effects of drugs targeting DNA-PK in breast c
187 uate the molecular mechanisms underlying the anticancer effects of EF24 on CCA tumor growth and metas
190 f evidence supports the in vitro and in vivo anticancer effects of genistein, a soybean isoflavone.
193 N-gammaR were particularly important for the anticancer effects of HDACi, and vorinostat and IFN-gamm
194 biology and (4) pharmacological data showing anticancer effects of HIF-1 inhibitors in mouse models o
196 changed in recent years owing to the robust anticancer effects of immune checkpoint inhibitors (ICI)
197 ile the molecular events associated with the anticancer effects of JS-K, HL-60 leukemia cells were tr
200 o cell culture models were sensitized to the anticancer effects of NKG2D-mediated NK cell and macroph
201 TR is an important upstream modulator of the anticancer effects of NSAIDs and that ibuprofen inductio
202 chanisms have been postulated to explain the anticancer effects of NSAIDs, they do not involve merely
203 study, we explored if paricalcitol enhanced anticancer effects of other clinically useful drugs in v
211 r a preclinical rationale to investigate the anticancer effects of PTP1B inhibitors currently being s
216 its physical interaction with AP-1, promotes anticancer effects of retinoids by potentiating their an
219 date the molecular mechanisms underlying the anticancer effects of RO extract, both independently and
221 This study aimed to explore the combined anticancer effects of Rumex obtusifolius (RO) extract an
225 contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds.
226 tibody enhances the ferroptosis-inducing and anticancer effects of sorafenib on HCC patient-derived x
228 agonist-induced gene expression and enhances anticancer effects of the chemotherapy paclitaxel, a kno
230 ct immune system was required for the robust anticancer effects of the HDACi vorinostat and panobinos
233 well as a direct comparison of the in vitro anticancer effects of the two clinically available COX-2
237 aditional Chinese medicine, can modulate the anticancer effects of TRAIL, the cytokine that is curren
241 erpene from tropical ginger, can enhance the anticancer effects of tumor necrosis factor-related apop
242 The mechanisms underlying the potential 'anticancer' effects of exercise remain poorly understood
243 ination resulted in a remarkable synergistic anticancer effect on intracranial human and murine gliob
244 ibitors, VER-155008 or JG-98, exerted potent anticancer effect on NSCLC cells, albeit the final outco
245 xel in combination with 3d had a synergistic anticancer effect on reduction of programmed death-ligan
247 inhibit ATP1A1 function, exhibited selective anticancer effects on STK11 mutant lung cancer cell line
248 (IPA) suggested that curcumin may exert its anticancer effects over multiple critical biological pat
249 ity, effective tumour targeting and superior anticancer effects owing to favourable doxorubicin-bindi
250 insertor administration resulted in enhanced anticancer effects, pointing to a need for more selectiv
252 sponses have been shown to mediate prominent anticancer effects, reflecting not only their direct cyt
254 xpression in HPV-positive HNSCC has a global anticancer effect resulting in a decrease in cell prolif
255 c-Myc/miR-29c/REV3L signalling may have dual anticancer effects, sensitizing the resistant tumours to
256 ta suggest that TLS inhibition may have dual anticancer effects, sensitizing tumors to therapy as wel
257 erior in their selective apoptosis-mediating anticancer effect than free form of these proteins and 5
258 doxorubicin (DOX) delivery to the tumor and anticancer effect than the RIATC prodrug that lacks apop
260 ogenic effect, and a significant "bystander" anticancer effect that leads to enhanced production of t
262 inhibiting telomerase may not result in the anticancer effects that were originally hypothesized.
264 CDK1/2 and EGFR inhibitors have a synergetic anticancer effect through the downregulation of ERK1/2 s
265 d transferrin receptor and exhibit potential anticancer effects through a signaling mechanism that is
267 own that tumor treating fields achieve their anticancer effects through multiple mechanisms of action
268 e, bortezomib) are unlikely to mediate their anticancer effects through suppression of NF-kappaB.
269 ic acid (trans-RA) and other retinoids exert anticancer effects through two types of retinoid recepto
270 methylation and to link them to the observed anticancer effects to fully understand the functions of
271 ng the first molecular target with potential anticancer effect, translating into the development of t
273 d long-term use of NSAIDs is required for an anticancer effect--up to 15 or 20 years before a reduced
274 To correlate the AT1 receptor blockage to anticancer effects, VEGF levels and microvessel densitie
275 AR gamma agonists coordinately mediate their anticancer effect via both COX-dependent (inhibition of
277 xerts its highly potent in vitro and in vivo anticancer effects via tubulin-based antimitotic mechani
278 atural product previously unreported to have anticancer effects, was found to have potent antimyeloma
280 her inhibition of retrotranspositions has an anticancer effect, we used treatment with the nucleoside
281 al inhibition of MAPK13 enhances rapamycin's anticancer effects, which suggests that MAPK13 confers a
282 ent chloroquine also displayed a synergistic anticancer effect with 2DG, whereas glucose deprivation